Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
4 Fte (6)
Lobbyists with EP accreditation
1
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Pharma Deutschland e.V (Pharma Deutschland)
EU Transparency Register
945120918083-26 First registered on 06 Jul 2015
Goals / Remit
Pharma Deutschland e.V. represents the entire spectrum of manufacturers of pharmaceutical products, in particular prescription and over-the-counter medicines, material and dental medical devices as well as digital health and care applications.
Pharma Deutschland is the pharmaceutical industry association with the largest number of members in Germany. It reperesents the interests of around 400 member companies that employ approximately 80,000 people in Germany. Globally active pharmaceutical manufacturers are just as actively involved in the diverse work of the association as the broadly represented medium-sized companies.Main EU files targeted
- EU Pharmaceutical Strategy
- Revision of the general pharmaceutical legislation
- Revision on EU legislation on medicines for children and for rare diseases
- Revision of the legislation on supplementary protection certificates (SPCs)
- Health Technology Assessment
- Falsified Medicines Directive
- Pharmacovigilance framework
- Clinical Trials Regulation
- Sustainability & Pharmaceuticals in the environment (e.g. - Urban Waste Water treatment directive and Water Quality)
- Health Claims Regulation
- Interlectual Property
- European Health Data Space
- Brexit Implementation
- EMA Mandate
- European Health Emergency Preparedness and Response Authority (HERA)
- Artifical Intelligence
- Implementation of Medical Device Directive
- AI Act
- Security of supplyAddress
Head Office
Ubierstr. 71-73
Bonn 53173
GERMANYEU Office
Ubierstr. 71-73
Bonn 53173
GERMANYWebsite
-
People
Total lobbyists declared
6
Employment time Lobbyists 100% 2 50% 4 Lobbyists (Full time equivalent)
4
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 21 Sep 2024
Name Start date End Date Henrik REIMER 04 Sep 2024 04 Sep 2025 Hubertus CRANZ 09 Sep 2023 07 Sep 2024 Anna WEHAGE 09 Sep 2023 07 Sep 2024 Anna WEHAGE 29 Oct 2022 09 Sep 2023 Hubertus CRANZ 18 Oct 2022 09 Sep 2023 Anna WEHAGE 30 Oct 2021 29 Oct 2022 Ms Wehage ANNA 30 Oct 2021 10 Jun 2022 Hubertus CRANZ 30 Oct 2021 18 Oct 2022 Hubertus CRANZ 26 Aug 2020 26 Aug 2021 Ms Nadine NÖLTE 13 Feb 2020 01 Mar 2021 Ms Susan KAFFENBERGER 22 Jan 2020 07 Oct 2020 Mr Hubertus CRANZ, DR. 14 Jun 2019 01 Jul 2020 Mr Dr Martin WEISER 10 Nov 2018 14 Jun 2019 Ms Susan KAFFENBERGER 10 Nov 2018 09 Nov 2019 Mr Johannes KOCH 30 Jan 2018 02 Nov 2018 Mr Johannes KOCH 23 Jan 2017 10 Jan 2018 Mr Johannes KOCH 04 Aug 2015 30 Jul 2016 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
German Chemical Industry Association (VCI) https://www.vci.de/startseite.jsp
Critical Medicines Alliance (CMA)https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/overview/critical-medicines-alliance_en
AESGP (Association Européenne des Spécialités Pharmaceutiques Grand Public) https://aesgp.eu/
Deutsche Akademie für Integrative Medizin (DAfIM) https://dafim.info/
action medeor https://medeor.de/de/
Initiative medicines for children“ (“Initiative Arzneimittel für Kinder”, IKAM) http://www.arzneimittel4kids.de/
Cooperation Phytopharmaceuticals https://www.koop-phyto.org/
Research Association of Drug Manufacturers (FAH) https://fah-bonn.de/
INTEGRITAS, the “Association for fair advertising of remedies" https://www.integritas-hwg.de/Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
Publications(exerpt):
- Brexit and its consequences fpr the German Pharmaceutical industry
- Opinion of the German Medicines Manufacturers‘ Association (BAH) on European Health Data Space (EHDS)
- Stellungnahme zum Trilog für eine Verordnung des Europäischen Parlaments und des Rates zu einer verstärkten Rolle der Europäischen Arzneimittel-Agentur bei der Krisenvorsorge und dem Krisenmanagement in Bezug auf Arzneimittel und Medizinprodukte
- Stellungnahme zur "Evaluation and Revision of the General Pharmaceutical Legislation"
- Position Paper on the Inception Impact Assessment of the European Commission on building a European Health Emergency Preparedness and Response Authority (HERA)
- BAH-Positionspapier: Herausforderungen bei der Implementierung der MDR
- BAH-Positionspapier zum EU-Regulierungsrahmen für Künstliche Intelligenz
- BAH-Stellungnahme zur Revision der EU-Arzneimittel-Gesetzgebung
- BAH-Positionspapier zur Überarbeitung der kommunalen Abwasserrichtlinie
Events:
- High level conference on the future of medicines (2020), part of the associated programme of the German Federal Ministry of Health in the framework of the German Presidency of the Council of the EU 2020.Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 30 Nov 2020 Location Online Subject Future of Medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)